Related Experiment Video
Updated: Apr 18, 2026

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice
Published on: May 15, 2019
The role of hepcidin in chronic mild stress-induced depression
Fereshteh Farajdokht1, Mansoureh Soleimani2, Sara Mehrpouya1
1Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Insights
Inhibition of hepcidin, a key player in inflammation and iron balance, effectively reduced depressive behaviors and associated biochemical changes in a rat model of chronic stress-induced depression.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Depression is a widespread mental health condition with unclear origins.
- Chronic stress can trigger depression through increased cytokine production.
- Hepcidin, an iron regulator, influences inflammation and iron homeostasis.
Purpose of the Study:
- To investigate the role of hepcidin in stress-induced depression.
- To examine the effects of a hepcidin inhibitor on depressive behaviors and related physiological changes.
Main Methods:
- A rat model of depression was established using chronic unpredictable mild stress for 28 days.
- Stressed rats were treated with varying doses of dalteparin, a hepcidin inhibitor.
- Depressive behaviors, serum interleukin-6 levels, hepcidin mRNA, and hippocampal iron content were assessed.
Main Results:
- Chronic mild stress induced depressive-like behaviors and elevated serum interleukin-6 levels.
- Stress led to increased hepcidin mRNA and iron content in the hippocampus.
- Dalteparin treatment successfully blocked these stress-induced changes.
Conclusions:
- Hepcidin plays a significant role in the pathophysiology of stress-induced depression.
- Inhibiting hepcidin may offer a therapeutic strategy for depressive disorders.
- Targeting hepcidin could mitigate pathological changes associated with chronic stress.
Abstract:
Depression is one of the most prevalent challenges of mental conditions. Yet its exact etiology has not been clear. Chronic stress increases the production of cytokines, which can lead to depression. Hepcidin, an iron modulator, is involved in the inflammation process as well as iron homeostasis. This study was designed to investigate the role of hepcidin, on stress-induced depression. 60 male wistar rats were entered the experiment. We used a chronic unpredictable mild stress (for 28 days) as a rat model of depression. In stressed group, three subgroups were treated with three different doses of dalteparin (a hepcidin inhibitor): 70IU/kg, 100IU/kg and 140IU/kg daily, for 4 weeks. The animals in the stressed group had more depressive-like behavior than the control group. Moreover, chronic mild stress produced an increased serum interleukin-6 levels. These effects were accompanied by an obvious increase in hepcidin mRNA level and iron content in the hippocampus. These changes were blocked by the injection of dalteparin. In conclusion, inhibition of hepcidin may reduce many pathological changes seen in stress-induced depressive disorders.
More Related Videos
Related Concept Videos
Hypothalamic-Pituitary Axis
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...

